BioCentury | Nov 25, 1996
Emerging Company Profile

Thallia Pharmaceuticals

...a l'Energie Atomique, and INSERM Number of employees: 21 Funds raised: $8.5 million Investors: Sofinnova, Finovelec...
BioCentury | Dec 12, 1994
Strategy

A new name in liposomal drug delivery

...was to announce today that it has raised $3.7 million in financing from investors Sofinnova, Finovelec...
BioCentury | Jan 17, 1994
Strategy

Pedigreed team hunting for projects

...Deleage, Advent Ltd., Biotechnology Investments Ltd., Medical Science Partners, Advent International, Alta Berkeley III C.V., Finovelec...
Items per page:
1 - 3 of 3
BioCentury | Nov 25, 1996
Emerging Company Profile

Thallia Pharmaceuticals

...a l'Energie Atomique, and INSERM Number of employees: 21 Funds raised: $8.5 million Investors: Sofinnova, Finovelec...
BioCentury | Dec 12, 1994
Strategy

A new name in liposomal drug delivery

...was to announce today that it has raised $3.7 million in financing from investors Sofinnova, Finovelec...
BioCentury | Jan 17, 1994
Strategy

Pedigreed team hunting for projects

...Deleage, Advent Ltd., Biotechnology Investments Ltd., Medical Science Partners, Advent International, Alta Berkeley III C.V., Finovelec...
Items per page:
1 - 3 of 3